Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Ancient India used herbal cosmetics for beauty, health, and well-being, with diverse natural formulations.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

An 8-year-old boy with hair-pulling disorder had a bald patch that was confirmed not to be a fungal infection and was treated with therapy.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.